SCEINTIFIC CORE
科学核心
基本信息
- 批准号:8215274
- 负责人:
- 金额:$ 54.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至 2013-01-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAnimal ExperimentsAnimalsAntibodiesAntigensBackBehavioralBiochemicalBiologicalBreedingCellsCommunicationDevelopmentDiseaseEmbryoEnsureEtiologyEukaryotaFreezingGeneticGenetic ScreeningGenetically Modified AnimalsGenotypeGoalsHuman ResourcesIn VitroInbred StrainIndividualKnowledgeMaintenanceModificationMolecularMusNeuronsPeptide antibodiesPhospho-Specific AntibodiesPhosphorylationPreparationProductionProgram Research Project GrantsReagentRecombinantsResearchResearch PersonnelSignal TransductionSignaling MoleculeSpecialistSpeedTestingTimeTransformed Cell LineTransgenic MiceYeastsbasecDNA Librarycongeniccostcost effectivegenetic manipulationinsightmeetingsmouse modelnovelpolyclonal antibodyprotein phosphatase inhibitor-2protein protein interactionreconstitutionresearch studysecretasetissue culture
项目摘要
Studies of the neuropathological alterations seen in Alzheimer's Disease (AD) and the molecular and cellular
changes underlying them have yielded a wealth of information regarding the etiology of this devastating
disease. The combined studies outlined in Projects 1-3 will extend upon this existing knowledge with
rigorous cell biological, molecular, biochemical, behavioral, and electrophysiological studies of neuronal cells
in vitro and in several mouse models of AD. These studies have the potential to provide greater insight into
the etiology of AD as well as to elucidate possible novel targets for AD therapy. The Scientific Core will be a
center devoted to facilitating the experiments proposed in Projects 1-3 that require the use of primary
neuronal and organotypic cultures, genetically modified animals, immunological reagents, and yeast-
reconstituted y-secretase. The existence of this centralized facility will ensure that the experiments outlined in
Projects 1-3 will be completed in the most timely and cost-effective manner. Many of the studies proposed in
this Program Project Grant will require the use of high-quality neuronal cultures to validate initial findings
from transformed cell lines. In Specific Aim I, the Core will be responsible for performing the routine tasks
involved in the preparation of primary neuronal and organotypic cultures needed by Projects 1-3. As all
of the findings of Projects 1-3 will ultimately be validated and tested in intact animals, the experiments
outlined in these Projects will also require the breeding and maintenance of genetically modified animals.
Thus the breeding and maintenance of transgenic mice is Specific Aim II of the Core. In order to aid in
the characterization of new protein-protein interactions, protein localization, and protein phosphorylation, the
Scientific Core will be a keysource of new polyclonal antibodies, including phosphorylation state-
specific antibodies, as described in Specific Aim III. Finally, the reconstitution of y-secretaseactivity in the
simple eukaryote P. pastoris for genetic manipulation and screening is Specific Aim IV.
阿尔茨海默病(AD)神经病理学改变及其分子和细胞学改变的研究
它们背后的变化已经产生了大量关于这种毁灭性疾病病因学的信息。
疾病项目1 - 3中概述的综合研究将在现有知识的基础上扩展,
对神经元细胞进行严格的细胞生物学、分子学、生物化学、行为学和电生理学研究
在体外和几种AD小鼠模型中。这些研究有可能提供更深入的了解,
AD的病因学以及阐明AD治疗的可能的新靶点。科学核心将是一个
该中心致力于促进项目1 - 3中提出的需要使用初级
神经元和器官型培养物、转基因动物、免疫试剂和酵母-
重组γ-分泌酶这一集中设施的存在将确保
项目1 - 3将以最及时和最具成本效益的方式完成。许多研究建议,
这项计划项目资助将需要使用高质量的神经元培养物来验证最初的发现
转化的细胞系。在具体目标I中,核心将负责执行日常任务
参与项目1 - 3所需的原代神经元和器官型培养物的制备。因为所有
项目1 - 3的发现最终将在完整的动物身上得到验证和测试,
这些项目中概述的生物多样性还要求繁殖和饲养转基因动物。
因此,转基因小鼠的培育和维持是第二个具体目标的核心。为了帮助
新的蛋白质-蛋白质相互作用,蛋白质定位和蛋白质磷酸化的表征,
科学核心将是新的多克隆抗体的关键来源,包括磷酸化状态-
特定抗体,如特定目标III中所述。最后,γ-分泌酶活性的重建,
用于遗传操作和筛选的简单真核生物巴斯德毕赤酵母是Specific Aim IV。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YONG I KIM其他文献
YONG I KIM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YONG I KIM', 18)}}的其他基金
AUTOIMMUNITY TO CALCIUM CHANNELS IN LAMBERT EATON SYNDRO
兰伯特·伊顿综合征中钙通道的自身免疫
- 批准号:
6540039 - 财政年份:1999
- 资助金额:
$ 54.93万 - 项目类别:
AUTOIMMUNITY TO CALCIUM CHANNELS IN LAMBERT EATON SYNDRO
兰伯特·伊顿综合征中钙通道的自身免疫
- 批准号:
6188014 - 财政年份:1999
- 资助金额:
$ 54.93万 - 项目类别:
AUTOIMMUNITY TO CALCIUM CHANNELS IN LAMBERT EATON SYNDRO
兰伯特·伊顿综合征中钙通道的自身免疫
- 批准号:
2911169 - 财政年份:1999
- 资助金额:
$ 54.93万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 54.93万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 54.93万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 54.93万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 54.93万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 54.93万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 54.93万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 54.93万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 54.93万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 54.93万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 54.93万 - 项目类别: